Strikingly, phorbol myristate acetate (PMA) treatment of THP-1 cells greatly enhanced (>1,000-fold) this early block (Fig. 2), with the levels of infection being too low for us to accurately enumerate following IFN-γ treatment. The gene discussed is IFNG; the disease is infection.